Thermo Fisher Scientific (TMO)
NYSE • Healthcare
April 2, 2026 at 20:00 UTC
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is a life-science tools and services company that helps laboratories, manufacturers, and health systems turn experiments into routine outcomes. It supplies technology and know-how for sample preparation, measurement, and regulated production, with delivery models that range from instruments on site to outsourced scientific services. The approach is practical: keep methods consistent, documentation clear, and supply reliable so work can move from discovery to everyday use without constant reinvention. Teams support customers in research, diagnostics, and bioproduction, aligning procedures with standards that travel across regions. By pairing science with service, the company positions itself as infrastructure for modern laboratories and plants rather than a single product bet, aiming to make complex workflows feel predictable in real settings.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
Thermo Fisher Scientific's Technical Indicators Summary
Thermo Fisher is in a neutral technical state with short-term averages near the price and longer-term averages remaining above, producing conflicting signals across timeframes. Momentum shows some strength while MACD and RSI are essentially neutral, and ADX is elevated suggesting a strong but unclear directional backdrop. Volatility is moderate with ATR around the mid-teens and on-balance volume is mixed, leaving momentum and trend measures at odds. Technical takeaway: Neutral — opposing moving averages and mixed momentum create an indecisive technical setup.
| Indicator | Value |
|---|---|
RSI (14) | 47.61 |
Stochastic %K (14, 3, 3) | 77.61 |
CCI (20) | 60.78 |
WPR (14) | -31.68 |
Momentum (10) | 21.25 |
MFI | 75.08 |
MACD Level (12, 26) | -8.24 |
Bollinger Bands | $457.52 - $510.38 |
ATR (14) | $14.62 (2.97%) |
ADX (14) | 35.37 |
OBV | -4,273,800 |
Classic Pivot Point | $495.82 |
Fibonacci Pivot Point | $495.82 |
Simple Moving Averages | $483.95 - $554.71(5 indicators) |
Exponential Moving Averages | $486.63 - $527.15(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
End-of-day trade saw TMO unable to fully erase the -0.62% gap down from yesterday, settling near 491.46. End-of-day options data show heavy put demand in TMO, leaving the put/call ratio at 1.54. TMO couldn't erase yesterday's gap, with heavy put demand in options signaling near-term caution.
Price Change
from $491.32 close
-$0.11
Trading Volume
Below avg (1.8M)
1.6M
vs S&P 500 Today
Strong Underperformance
-3.19%
52-Week Position
Mid-range
41%
Updated: April 3, 2026 at 20:09 UTC
Quote Summary
TMO Headlines
Thermo Fisher prices $3.8B notes for Clario deal
February 10, 2026
AI boom powers chips, storage, and lab-tech deals
January 18, 2026